Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IPHA Innate Pharma > Company Profile
IPHA Innate Pharma
2.190
-0.100-4.37%
Symbol
IPHA
Company Name
Innate Pharma
Listing Date
10/17/2019
Establishment Date
1999
CEO
Dr. Mondher Mahjoubi, M.D.
Market
NASDAQ
Employees
215
Securities Type
DR
Fiscal Year Ends
12-31
Address
117, Avenue de Luminy
City
Marseille
Province
Provence-Alpes-Cote-dAzur
Country
France
Zip code
13009
Phone
33-4-30-30-30-30
Profile
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.
Company Overview
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.
CEO: Dr. Mondher Mahjoubi, M.D.
Market: NASDAQ
Listing Date: 10/17/2019
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist